omeprazole has been researched along with Exanthema in 9 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
Exanthema: Diseases in which skin eruptions or rashes are a prominent manifestation. Classically, six such diseases were described with similar rashes; they were numbered in the order in which they were reported. Only the fourth (Duke's disease), fifth (ERYTHEMA INFECTIOSUM), and sixth (EXANTHEMA SUBITUM) numeric designations survive as occasional synonyms in current terminology.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Acute generalized exanthematous pustulosis (AGEP) comprises a group of eruptions characterized by several small sterile pustules over an erythematous-edematous skin." | 5.35 | [Acute generalized exanthematous pustulosis induced by omeprazole]. ( Martínez-Peñuela Virseda, JM; Nantes Castillejo, O; Valcayo Peñalba, A; Zozaya Urmeneta, JM, 2008) |
| "Rabeprazole is a new proton pump inhibitor with more potent acid suppressive and anti-Helicobacter effects." | 2.70 | Rabeprazole-based 3-day and 7-day triple therapy vs. omeprazole-based 7-day triple therapy for the treatment of Helicobacter pylori infection. ( Fung, FM; Hu, WH; Hui, CK; Hung, WK; Lai, KC; Lam, SK; Lau, P; Li, KF; Szeto, ML; Tong, TS; Wong, BC; Wong, WM; Yee, YK; Yip, AW; Yuen, MF, 2001) |
| "Omeprazole is a proton pump inhibition and ranitidine is an H2 histamine receptor antagonist widely used in the treatment of gastroesophageal reflex disease, peptic ulcer disease, Zollinger-Ellison syndrome and as a protector of the gastric mucosae." | 1.46 | Occupational contact allergy to omeprazole and ranitidine. ( Herrera-Mozo, I; Martí-Amengual, G; Sanz-Gallen, P, 2017) |
| "Acute generalized exanthematous pustulosis (AGEP) comprises a group of eruptions characterized by several small sterile pustules over an erythematous-edematous skin." | 1.35 | [Acute generalized exanthematous pustulosis induced by omeprazole]. ( Martínez-Peñuela Virseda, JM; Nantes Castillejo, O; Valcayo Peñalba, A; Zozaya Urmeneta, JM, 2008) |
| "Omeprazole was used in 90% of the patients; lansoprazole, in 7%." | 1.34 | Characteristics of children receiving proton pump inhibitors continuously for up to 11 years duration. ( El-Serag, HB; Hassall, E; Kerr, W, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Herrera-Mozo, I | 1 |
| Sanz-Gallen, P | 1 |
| Martí-Amengual, G | 1 |
| Kardaun, SH | 1 |
| Tupker, RA | 1 |
| Chularojanamontri, L | 1 |
| Jiamton, S | 1 |
| Manapajon, A | 1 |
| Suvanasuthi, S | 1 |
| Kulthanan, K | 1 |
| Dhana, N | 1 |
| Jongjarearnprasert, K | 1 |
| Wu, CJ | 1 |
| Hsu, PI | 1 |
| Lo, GH | 1 |
| Lo, CC | 1 |
| Lin, CK | 1 |
| Shie, CB | 1 |
| Peng, NJ | 1 |
| Tseng, HH | 1 |
| Jou, HS | 1 |
| Tsai, PM | 1 |
| Chen, A | 1 |
| Chen, JL | 1 |
| Lai, KH | 1 |
| Jacobs-Kosmin, D | 1 |
| Derk, CT | 1 |
| Sandorfi, N | 1 |
| Hassall, E | 1 |
| Kerr, W | 1 |
| El-Serag, HB | 1 |
| Nantes Castillejo, O | 1 |
| Zozaya Urmeneta, JM | 1 |
| Valcayo Peñalba, A | 1 |
| Martínez-Peñuela Virseda, JM | 1 |
| Dewerdt, S | 1 |
| Vaillant, L | 1 |
| Machet, L | 1 |
| de Muret, A | 1 |
| Lorette, G | 1 |
| Wong, BC | 1 |
| Wong, WM | 1 |
| Yee, YK | 1 |
| Hung, WK | 1 |
| Yip, AW | 1 |
| Szeto, ML | 1 |
| Li, KF | 1 |
| Lau, P | 1 |
| Fung, FM | 1 |
| Tong, TS | 1 |
| Lai, KC | 1 |
| Hu, WH | 1 |
| Yuen, MF | 1 |
| Hui, CK | 1 |
| Lam, SK | 1 |
2 trials available for omeprazole and Exanthema
| Article | Year |
|---|---|
Comparison of cetraxate-based and pantoprazole-based triple therapies in the treatment of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer | 2004 |
Rabeprazole-based 3-day and 7-day triple therapy vs. omeprazole-based 7-day triple therapy for the treatment of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Benzimid | 2001 |
7 other studies available for omeprazole and Exanthema
| Article | Year |
|---|---|
Occupational contact allergy to omeprazole and ranitidine.
Topics: Dermatitis, Occupational; Eczema; Exanthema; Histamine H2 Antagonists; Humans; Male; Middle Aged; Om | 2017 |
Symmetrical drug-related intertriginous and flexural exanthema (Baboon syndrome) induced by omeprazole.
Topics: Adult; Aged; Drug Eruptions; Exanthema; Female; Humans; Omeprazole; Proton Pump Inhibitors | 2012 |
Cutaneous reactions to proton pump inhibitors: a case-control study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Angioedema; Cas | 2012 |
Pantoprazole and perinuclear antineutrophil cytoplasmic antibody-associated vasculitis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Aged; Anti-Ulcer Agents; Antibodies, Antineu | 2006 |
Characteristics of children receiving proton pump inhibitors continuously for up to 11 years duration.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Age Distribution; Child; Child, Preschool; Cohort Studies; | 2007 |
[Acute generalized exanthematous pustulosis induced by omeprazole].
Topics: Acute Disease; Aged; Aged, 80 and over; Drug Eruptions; Exanthema; Female; Humans; Male; Middle Aged | 2008 |
Acute generalized exanthematous pustulosis induced by lansoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Infective Agents; Exanthema; Female; Humans; Lan | 1997 |